A study published in Cornea found that quantum molecular resonance, a technique using low-intensity, high-frequency electric currents to treat dry eye disease (DED), improved symptoms and some signs of the disorder. The study included 40 participants with DED and compared quantum molecular resonance treatment to sham treatment. Patients who underwent quantum molecular resonance reported significantly improved Ocular Surface Disease Index (OSDI) scores, as well as improvements in meibomian gland dysfunction (MGD) and corneal fluorescein staining (CFS) scores. There were no significant adverse events reported. The researchers suggest that if larger trials support the treatment’s efficacy, it could be considered an adjunct option in treating DED.
Source link
Quantum Molecular Resonance Shows Promise for Treating DED
